Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Stepping-stones to the further advancement of androgen-deprivation therapy for prostate cancer.

Stepping-stones to the further advancement of androgen-deprivation therapy for prostate cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Stepping-stones to the further advancement of androgen-deprivation therapy for prostate cancer. Abstract Text:

    tsutomu nishiyamaTsutomu Nishiyama,kazuya suzukiKazuya Suzuki,kazutoshi yamanaKazutoshi Yamana,etsuko tonegawaEtsuko Tonegawa,koichi wakoKoichi Wako,kota takahashiKota Takahashi,

    Androgen-deprivation therapy has remained the critical therapeutic option for patients with advanced prostate cancer for over 60 years. Patients with poorly differentiated prostate cancer have low dihydrotestosterone levels in the prostate. After androgen-deprivation therapy, dihydrotestosterone levels in the prostate remain at approximately 25% of the level measured before therapy. The addition of a nonsteroidal anti-androgen to luteinizing hormone-releasing hormone analog or surgical castration significantly reduces the risk of all causes of death by 8%, which translates into a small, but significant, improvement in the 5-year survival of 2.9% over castration alone. The biologically aggressive prostate cancer cells may have an androgen receptor with heightened sensitivity to low dihydrotestosterone levels from the early stage of androgen-dependent disease. It is necessary to consider the androgen environment and the status of the androgen receptor in the prostate in order to improve the clinical efficacy of androgen-deprivation therapy and the quality of life of patients.

    Stepping-stones to the further advancement of androgen-deprivation therapy for prostate cancer. Publishing Authors By Initials

    t nishiyamaT Nishiyama,k suzukiK Suzuki,k yamanaK Yamana,e tonegawaE Tonegawa,k wakoK Wako,k takahashiK Takahashi,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Stepping-stones to the further advancement of androgen-deprivation therapy for prostate cancer. Journal Published:

    PUBLICATION TYPE: Review

    Journal: Expert review of anticancer therapy

    VOLUME: 6

    Page Numbers: 259-68

    Journal Abbreviation: Expert Rev Anticancer Ther

    ISSN: 1744-8328

    DAY: 5

    MONTH: Feb

    YEAR: 2006

    Stepping-stones to the further advancement of androgen-deprivation therapy for prostate cancer. Information

    Number of References: 71

    LANGUAGE: eng

    NlmUniqueID: 101123358

    Stepping-stones to the further advancement of androgen-deprivation therapy for prostate cancer. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Stepping-stones to the further advancement of androgen-deprivation therapy for prostate cancer. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Stepping-stones to the further advancement of androgen-deprivation therapy for prostate cancer.

    AFFILIATION: Division of Urology, Department of Regenerative and Transplant Medicine, Niigata University Graduate School of Medical and Dental Sciences, Asahimachi 1-757, Niigata 95 1-8510, Japan. nisiyama@med.niigata-u.ac.jp

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Expert Rev Anticancer Ther

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Stepping-stones to the further advancement of androgen-deprivation therapy for prostate cancer Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News